Notice Regarding Dividend of Surplus (Dividend Increase)
Filed with TSE · · 2 pages · English
In the deck
Earlier from Fuji Pharma
- Consolidated Financial Results for the Nine Months Ended June 30, 2026 [Japanese GAAP]
- TABLE-Fuji Pharmaceutical -2025/26 div forecast
- TABLE-Fuji Pharmaceutical -Q1 group results
- TABLE-Fuji Pharmaceutical -2024/25 group results
Follow Fuji Pharma into a list and get an email when it puts out news.
Follow Fuji Pharma